Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis

Study limitation reported by the research below: “The cirrhosis cohort is relatively small (n=234 of 2,395), which may limit statistical power for subgroup analyses.”